Qube Research & Technologies LTD Sigilon Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.48 - $0.86 $551 - $988
-1,149 Reduced 10.16%
10,159 $5,000
Q2 2022

Aug 15, 2022
BUY
$0.74 - $1.64 $8,367 - $18,545
11,308 New
11,308 $9,000
Q1 2021

May 14, 2021
SELL
$18.76 - $40.91 $263,915 - $575,521
-14,068 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$27.6 - $48.03 $388,276 - $675,686
14,068 New
14,068 $676,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email